Royalty Pharma plc (RPRX) Net Income towards Common Stockholders (2019 - 2026)
Royalty Pharma (RPRX) reported Net Income towards Common Stockholders of $17.88 million for Q2 2026, down 44.4% from $32.18 million a year earlier and down 93.9% from the prior quarter.
Powered by 
Analysis
Royalty Pharma plc (RPRX) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Royalty Pharma's Net Income towards Common Stockholders came in at $815 million, down 20.4% year-over-year; for FY2025, it was $770.95 million, down 10.2% from FY2024.
- Net Income towards Common Stockholders has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- By year, Net Income towards Common Stockholders came in at $858.98 million in FY2024 (-24.3%), $1.13 billion in FY2023, $42.83 million in FY2022 (-93.1%) and $619.73 million in FY2021 (-36.4%).
- The Q2 2026 figure ranks as the lowest quarterly Net Income towards Common Stockholders since Q1 2024.
- Year over year, Net Income towards Common Stockholders gained in three of the last seven quarters, with growth averaging 66.1%.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q3 2024 (growth of 654.3%); the low point was Q1 2024 (a decline of 98.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $294.69 million (Q1 2026), $214.21 million (Q4 2025) and $288.22 million (Q3 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.88 Mn |
| Mar 31, 2026 | 294.69 Mn |
| Dec 31, 2025 | 214.21 Mn |
| Sep 30, 2025 | 288.22 Mn |
| Jun 30, 2025 | 32.18 Mn |
| Mar 31, 2025 | 239.35 Mn |
| Dec 31, 2024 | 208.21 Mn |
| Sep 30, 2024 | 543.99 Mn |
| Jun 30, 2024 | 102.00 Mn |
| Mar 31, 2024 | 4.78 Mn |
| Dec 31, 2023 | 494.34 Mn |
| Sep 30, 2023 | 72.11 Mn |
| Jun 30, 2023 | 227.63 Mn |
| Mar 31, 2023 | 340.76 Mn |
| Dec 31, 2022 | -456.08 Mn |
| Sep 30, 2022 | 142.65 Mn |
| Jun 30, 2022 | 304.50 Mn |
| Mar 31, 2022 | 51.76 Mn |
| Dec 31, 2021 | 7.90 Mn |
| Sep 30, 2021 | 101.93 Mn |
API Access
Royalty Pharma plc Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();